Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction
Griesinger, Georg; Tournaye, Herman; Macklon, Nick; Petraglia, Felice; Arck, Petra; Blockeel, Christophe; van Amsterdam, Peter; Pexman-Fieth, Claire; Fauser, Bart CJM
(2019) Reproductive Biomedicine Online, volume 38, issue 2, pp. 249 - 259
(Article)
Abstract
The pharmacological and physiological profiles of progestogens used for luteal phase support during assisted reproductive technology are likely to be important in guiding clinical choice towards the most appropriate treatment option. Various micronized progesterone formulations with differing pharmacological profiles have been investigated for several purposes. Dydrogesterone, a stereoisomer of progesterone,
... read more
is available in an oral form with high oral bioavailability; it has been used to treat a variety of conditions related to progesterone deficiency since the 1960s and has recently been approved for luteal phase support as part of an assisted reproductive technology treatment. The primary objective of this review is to critically analyse the clinical implications of the pharmacological and physiological properties of dydrogesterone for its uses in luteal phase support and in early pregnancy.
show less
Download/Full Text
The full text of this publication is not available.
Keywords: Duphaston, Dydrogesterone, In-vitro fertilization, Luteal phase support, Pharmacological profile, Progesterone, Dydrogesterone/therapeutic use, Progestins/therapeutic use, Humans, Luteal Phase/drug effects, Reproductive Techniques, Assisted, Pregnancy, Female, Pregnancy Rate, Review, Journal Article
ISSN: 1472-6483
Publisher: Elsevier
Note: Funding Information: Editorial support was provided by Josh Lilly of Alpharmaxim Healthcare Communications. Publisher Copyright: © 2018 Reproductive Healthcare Ltd. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.
(Peer reviewed)